121 related articles for article (PubMed ID: 36046033)
1. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming.
Lu X; Wu Y; Cao R; Yu X; Gong J
Anim Cells Syst (Seoul); 2022; 26(4):148-157. PubMed ID: 36046033
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.
Amrutkar M; Berg K; Balto A; Skilbrei MG; Finstadsveen AV; Aasrum M; Gladhaug IP; Verbeke CS
Cancer Cell Int; 2023 Jan; 23(1):9. PubMed ID: 36658582
[TBL] [Abstract][Full Text] [Related]
3. Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells.
Kiss K; Baghy K; Spisák S; Szanyi S; Tulassay Z; Zalatnai A; Löhr JM; Jesenofsky R; Kovalszky I; Firneisz G
PLoS One; 2015; 10(5):e0128059. PubMed ID: 26010611
[TBL] [Abstract][Full Text] [Related]
4. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches.
Ashrafizadeh M; Luo K; Zhang W; Reza Aref A; Zhang X
Environ Res; 2024 Jan; 240(Pt 2):117443. PubMed ID: 37863168
[TBL] [Abstract][Full Text] [Related]
5. Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer
Chi Y; Xin H; Liu Z
Front Oncol; 2021; 11():671082. PubMed ID: 34868904
[TBL] [Abstract][Full Text] [Related]
6. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
7. CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.
Liu Y; Xia L; Dong L; Wang J; Xiao Q; Yu X; Zhu H
Cancer Manag Res; 2020; 12():921-929. PubMed ID: 32104074
[TBL] [Abstract][Full Text] [Related]
8. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.
Amrutkar M; Gladhaug IP
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546284
[TBL] [Abstract][Full Text] [Related]
9. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.
Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovačević Ž
J Biol Chem; 2022 Mar; 298(3):101608. PubMed ID: 35065073
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
11. AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transition.
Wang X; Song Z; Chen F; Yang X; Wu B; Xie S; Zheng X; Cai Y; Chen W; Zhong Z
Am J Transl Res; 2018; 10(12):4095-4106. PubMed ID: 30662653
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
Cao W; Zeng Z; He Z; Lei S
Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor.
Eguchi D; Ikenaga N; Ohuchida K; Kozono S; Cui L; Fujiwara K; Fujino M; Ohtsuka T; Mizumoto K; Tanaka M
J Surg Res; 2013 May; 181(2):225-33. PubMed ID: 22795353
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944.
Gao G; Li X; Wu H; Huang LL; Lin YX; Huo Z; Xiang ZY; Zhou X
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259332
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
Li M; Guo H; Wang Q; Chen K; Marko K; Tian X; Yang Y
Cancer Lett; 2020 Oct; 490():20-30. PubMed ID: 32585413
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF.
Liu Y; Wang J; Dong L; Xia L; Zhu H; Li Z; Yu X
Onco Targets Ther; 2019; 12():8207-8216. PubMed ID: 31632071
[TBL] [Abstract][Full Text] [Related]
17. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.
Wang W; Zhou X; Kong L; Pan Z; Chen G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672622
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
Qian D; Lu Z; Xu Q; Wu P; Tian L; Zhao L; Cai B; Yin J; Wu Y; Staveley-O'Carroll KF; Jiang K; Miao Y; Li G
Cancer Lett; 2017 Jul; 397():43-51. PubMed ID: 28336327
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model.
Kumar V; Sethi B; Staller DW; Shrestha P; Mahato RI
Cell Death Discov; 2024 Mar; 10(1):158. PubMed ID: 38553450
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway.
Han L; Ma J; Duan W; Zhang L; Yu S; Xu Q; Lei J; Li X; Wang Z; Wu Z; Huang JH; Wu E; Ma Q; Ma Z
Oncotarget; 2016 Apr; 7(14):18146-58. PubMed ID: 26934446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
